Application of Synthetic Tumor-Specific Promoters Responsive to the Tumor Microenvironment.

about

Application of Synthetic Tumor-Specific Promoters Responsive to the Tumor Microenvironment.

Item

http://www.wikidata.org/entity/Q54366680

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Application of Synthetic Tumor ...... to the Tumor Microenvironment.

@en

Application of Synthetic Tumor ...... to the Tumor Microenvironment.

@nl

type

Item

label

Application of Synthetic Tumor ...... to the Tumor Microenvironment.

@en

Application of Synthetic Tumor ...... to the Tumor Microenvironment.

@nl

prefLabel

Application of Synthetic Tumor ...... to the Tumor Microenvironment.

@en

Application of Synthetic Tumor ...... to the Tumor Microenvironment.

@nl

P1476

Application of Synthetic Tumor ...... to the Tumor Microenvironment.

@en

P2093

Eduardo G Cafferata

http://www.w3.org/2001/XMLSchema#string

Felipe J Nuñez

http://www.w3.org/2001/XMLSchema#string

Maria A R Maenza

http://www.w3.org/2001/XMLSchema#string

Maria Veronica Lopez

http://www.w3.org/2001/XMLSchema#string

Osvaldo L Podhajcer

http://www.w3.org/2001/XMLSchema#string

P2860

Targeting the Wnt pathways for therapies

Suppression of TNF-alpha-induced apoptosis by NF-kappaB

Adenoviral vector-mediated gene transfer for human gene therapy.

Nucleosome positioning signals in genomic DNA

A tumor-stroma targeted oncolytic adenovirus replicated in human ovary cancer samples and inhibited growth of disseminated solid tumors in mice.

In vivo angiogenic activity and hypoxia induction of heterodimers of placenta growth factor/vascular endothelial growth factor

Gene regulation by nucleosome positioning.

A novel hybrid promoter responsive to pathophysiological and pharmacological regulation

In vivo gene therapy for prostate cancer: preclinical evaluation of two different enzyme-directed prodrug therapy systems delivered by identical adenovirus vectors.

Local delivery of beta interferon using an adeno-associated virus type 5 effectively inhibits adjuvant arthritis in rats.

P304

213-227

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/978-1-4939-7223-4_16

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

1651

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28801910

http://www.w3.org/2001/XMLSchema#string